Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2024-07-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 June 2024. It details movements in authorised/registered share capital, issued shares, treasury shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting monthly share capital and shareholding movements. It is not a financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital and share movements as required by the exchange rules. The document length is about 4692 characters, which is consistent with a detailed regulatory filing rather than a brief announcement or a full annual/interim report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-07-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report for movements in securities, specifically focusing on the movements in authorised/registered share capital, issued shares, treasury shares, and convertibles for Reliance Global Holdings Limited for the month ended 30 June 2024. It includes detailed tables of share capital changes, confirmations of compliance with listing rules, and other regulatory confirmations. The document is submitted to the Hong Kong Exchanges and Clearing Limited and references compliance with specific listing rules (Main Board Rule 13.25C / GEM Rule 17.27C). The content is regulatory in nature, reporting share capital and share issuance movements, but it is not a financial report like an annual or interim report, nor is it an earnings release or management discussion. It is a regulatory filing reporting share capital movements and confirmations related to securities issuance and compliance. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (over 12,000 characters) and detailed content confirm it is not a mere announcement but a substantive regulatory filing.
2024-07-02 English
FINAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2024
Annual Report Classification · 95% confidence The document is titled 'FINAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2024' and contains detailed audited consolidated financial statements including profit or loss, comprehensive income, financial position, segment information, revenue analysis, and notes on accounting policies. It covers a full fiscal year ending 31 March 2024 and includes comparative figures for the prior year. The content is comprehensive and includes actual financial data, not just an announcement or summary. The presence of detailed financial statements and notes indicates this is a full annual report rather than a brief earnings release or announcement. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2024
2024-06-27 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 24 JUNE 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on 24 June 2024 for Sisram Medical Ltd. It details the voting outcomes on various resolutions including receiving the audited financial statements, re-election of directors, appointment of auditors, and share buyback and issuance mandates. The document does not contain the full annual report or financial statements themselves but reports the voting results on these matters. The length is 4678 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-06-24 English
PROFIT WARNING
Regulatory Filings Classification · 95% confidence The document is titled 'PROFIT WARNING' and is an announcement made pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. It provides a preliminary assessment of the unaudited management accounts for the year ended 31 March 2024 (FY2024), indicating expected losses compared to the previous year. The announcement explicitly states that the final annual results will be disclosed later on 27 June 2024. The document is short (3536 characters) and serves as an early alert to shareholders and investors about expected financial performance, not a full financial report. It does not contain detailed financial statements or comprehensive analysis but is a regulatory announcement of expected results. Therefore, it fits best under Regulatory Filings (RNS) as a profit warning announcement rather than an Annual Report (10-K) or Earnings Release (ER).
2024-06-24 English
Next Day Disclosure Returns
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed information about share allotments, changes in issued shares, and confirmations related to compliance with listing rules. The document is a regulatory disclosure about share capital changes rather than a full financial report or earnings release. It is not a report publication announcement since it contains substantive disclosure data. This type of document fits the category of Share Issue/Capital Change announcements, which cover new share issues and capital structure changes.
2024-06-21 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.